Quantcast

Latest HspE7 Stories

2011-10-28 06:45:08

(Ivanhoe Newswire) — The rate of anal cancer is increasing, particularly among men who have sex with men. A new study shows that a vaccine, used to fight HPV, successfully lowers the rates of anal intraepithelial neoplasia (AIN), which leads to cancer. Anal cancer caused by human papillomavirus (HPV,) type 16 or 18, is preceded by AIN, grade 2 or 3, which is the abnormal cell growth in anal tissue that may progress to cancer. The study attempted to prevent anal cancer related to...

2011-09-14 22:12:54

The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance, according to a new study from researchers at Henry Ford Hospital. The study also reveals that laryngeal cancer patients with Medicare, who tend to be 65 and older, have a lower prevalence of HPV, suggesting that HPV infection may be closely tied to age and changes in sexual behavior with younger generations. "Our study is an important...

Two Doses Of HPV Vaccine May Offer Enough Protection
2011-09-09 13:18:27

  New government research shows that two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose treatment. According to the study published in the Journal of the National Cancer Institute, the findings come from an analysis of data from the National Cancer Institute's Costa Rica Vaccine Trial.  This trial has 7,466 women enrolled in it. The women were either given the HPV vaccine Cervarix or a Hepatitis A...

2011-05-03 14:48:15

A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists. University of Manchester researchers, working with colleagues in Canada, have discovered how the antiviral drug lopinavir attacks HPV by switching on a natural viral defence system in infected cells. The study, published in the journal Antiviral Therapy, builds on the team's previous work in 2006 that first identified lopinavir as a potential therapeutic...

2011-04-29 06:14:17

(Ivanhoe Newswire) --A long-term surveillance strategy for women treated for precancerous cervical lesions may be helping to prevent cervical cancer. A new study confirmed that the currently used post-treatment approach (three cytological smears) is effective for identifying women at long-term risk of cervical cancer. Researchers say this is important because about 15 percent of women diagnosed with high-grade cervical intraepithelial neoplasia (CIN) will develop recurrent disease, even if...

2011-02-28 07:00:00

SAN ANTONIO, Feb. 28, 2011 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope(TM) technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer. HPV status determined by the RNAscope(TM) HPV test was highly predictive of patient outcome and highly concordant with that determined by existing methods. Significantly, the RNAscope(TM) test under development demonstrated...

2010-11-23 18:01:00

BURGESS HILL, England, November 24, 2010 /PRNewswire-FirstCall/ -- - Landmark Study Confirms Accuracy of Roche's Human Papillomavirus Test for the Detection of Cervical Pre-Cancer Missed by Existing Screening Methods The largest ever registrational study for a diagnostic product, involving more than 47,000 women shows that the cobas(R) 4800 Human Papillomavirus (HPV) test from Roche, is able to improve the detection of pre-cancerous cells in women whose cervical smears tested...

2010-10-21 14:48:38

UC Davis research examines cost-effective strategies to reduce cancer incidence and death A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy. Joy Melnikow, professor in the Department of Family and Community Medicine and colleagues tested several follow-up screening strategies for the 500,000 American women diagnosed and treated for...

2010-07-21 15:04:00

Research: 4-year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar and vaginal intraepithelial neoplasia and anogenital warts: Randomized controlled trial Vaccination against certain types of human papillomavirus (HPV) gives strong and sustained protection against genital warts and pre-cancerous growths of the cervix, according to a new study published on bmj.com today. An international study found that the quadrivalent HPV vaccine is...

2010-06-08 18:04:53

Oropharyngeal cancer patients whose tumors in the upper part of the throat test positively for the human papillomavirus (HPV) have better overall survival than patients with HPV-negative disease, researchers from The University of Texas MD Anderson Cancer Center report in a study published in the New England Journal of Medicine. The study - the largest and most definitive to date completed in a joint effort with the Radiation Therapy Oncology Group (RTOG) - shows that tumor HPV status is a...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related